Instead of jumping from 2.5 mg directly to 5 mg, they use an intermediate step
Along with preclinical data indicating that long-acting GIPR agonists act in the brain to decrease body weight and food intake via GIPR signalling in inhibitory -aminobutyric acid-producing (GABAergic) neurons 5,6,7 , and by mitigating the emetic effects of GLP-1R agonism 8,9 , GIPRGLP-1R co-agonism has been established as a highly effective strategy for the management of obesity, type 2 diabetes and MASH
Furthermore, while the efficacy of these synthetic drugs is remarkably high, the burden of gastrointestinal adverse events remains a challenge that requires carefully monitored dose escalation
Request that your physician document: specific BMI and weight history, detailed comorbidities with dates of diagnosis, all prior weight-loss medication trials (name, dose, duration, outcome), and current biomarker labs
Get started with Hers Interested in trying Hers
Many peptide systems discussed herein have been repeatedly shown to exert robust physiological effects in vivo , often across multiple species, yet lack approved therapeutic analogs or advanced clinical programs despite decades of investigation